Veracyte Inc

Veracyte Inc

VCYT

Get informed when a big investor buys or sells

+ Follow
Market Cap$3.77B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Veracyte IncVeracyte Inc32.8-8%6.1-
$55.08

Target Price by Analysts

29.4% upsideVeracyte Target Price DetailsTarget Price
$41.15

Current Fair Value

3.4% downside

Overvalued by 3.4% based on the discounted cash flow analysis.

Share Statistics

Market cap$3.77 Billion
Enterprise Value$3.51 Billion
Dividend Yield$- (-)
Earnings per Share$0.84
Beta1.93
Outstanding Shares79,656,250

Return

Return on Equity8.25%ROE
Return on Assets7.70%
Return on Invested Capital7.45%

Valuation & Multiples

P/E Ratio32.79P/E Ratio
PEG-1.21PEG
Price to Sales6.08Price to Sales
Price to Book Ratio2.5Price to Book Ratio
Enterprise Value to Revenue6.24
Enterprise Value to EBIT33.09
Enterprise Value to Net Income30
Total Debt to Enterprise0.01
Debt to Equity0.03Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
August 5, 2026
EPS Estimate
$0.44
Average shareholder expectation
Revenue Estimate
$144.56 M
Average shareholder expectation

Next Earnings Call

Expected Date
November 3, 2026
EPS Estimate
$0.43
Average shareholder expectation
Revenue Estimate
$147.15 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.0000 12.01%
Total Calls- 100.00%
Total Puts- 100.00%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %31.54% 80.81%
Total Invested$1.47B 48.28%
Investors Holding151 189.00%

ESG Score

No data

About Veracyte Inc

CEO: Bonnie Anderson